Controversies in Surgical Management of the Node-Positive Neck After Chemoradiation

Seminars in Radiation Oncology

Volumn 19, Issue 1, 2009, Pages 24-28

  Lango, Miriam N ^a   Myers, Jeffrey N ^b   Garden, Adam S ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

AUSTRALIA; AUTHOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; FIBROSIS; HEAD AND NECK CANCER; INTERVENTION STUDY; MORBIDITY; NECK; NECK DISSECTION; OROPHARYNX CANCER; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIODIAGNOSIS; RECURRENT DISEASE; REVIEW; RISK; SALVAGE THERAPY; SCAR FORMATION; THERAPY EFFECT; TREATMENT RESPONSE; WOUND HEALING;

CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NECK DISSECTION; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 56349161113     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2008.09.005     Document Type: Review

References (39)

1. Conley J. Radical neck dissection. Laryngoscope 85 (1975) 1344-1352
2. Davidson B.J., Newkirk K.A., Harter K.W., et al. Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg 125 (1999) 401-405
3. Sassler A.M., Esclamado R.M., and Wolf G.T. Surgery after organ preservation therapy. Analysis of wound complications. Arch Otolaryngol Head Neck Surg 121 (1995) 162-165
4. Lavertu P., Bonafede J.P., Adelstein D.J., et al. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 124 (1998) 401-406
5. Morgan J.E., Breau R.L., Suen J.Y., et al. Surgical wound complications after intensive chemoradiotherapy for advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 133 (2007) 10-14
6. Grabenbauer G.G., Rodel C., Ernst-Stecken A., et al. Neck dissection following radiochemotherapy of advanced head and neck cancer-For selected cases only?. Radiother Oncol 66 (2003) 57-63
7. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group(RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
8. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
9. Ang K.K., Harris J., Garden A.S., et al. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation therapy group phase II trial 99-14. J Clin Oncol 23 (2005) 3008-3015
10. Garden A.S., Harris J., Vokes E.E., et al. Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol 22 (2004) 2856-2864
11. McHam S.A., Adelstein D.J., Rybicki L.A., et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?. Head Neck 25 (2003) 791-798
12. Koch W., and Sidransky D. Molecular markers of radiation effectiveness in head and neck squamous cell carcinoma. Semin Radiat Oncol 14 (2004) 130-138
13. Stenson K.M., Haraf D.J., Pelzer H., et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: The feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 126 (2000) 950-956
14. Frank D.K., Hu K.S., Culliney B.E., et al. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Laryngoscope 115 (2005) 1015-1020
15. Argiris A., Stenson K.M., Brockstein B.E., et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 26 (2004) 447-455
16. Goguen L.A., Posner M.R., Tishler R.B., et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 132 (2006) 526-531
17. Robbins K.T., Doweck I., Samant S., et al. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation. Arch Otolaryngol Head Neck Surg 131 (2005) 965-969
18. Liauw S.L., Mancuso A.A., Amdur R.J., et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: The use of computed tomography to manage the neck. J Clin Oncol 24 (2006) 1421-1427
19. Corry J., Peters L., Fisher R., et al. N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-Results of Trans Tasman Radiation Oncology Group Study 98.02. Head Neck 30 (2008) 737-742
20. Rogers J.W., Greven K.M., McGuirt W.F., et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?. Int J Radiat Oncol Biol Phys 58 (2004) 694-697
21. Gourin C.G., Williams H.T., Seabolt W.N., et al. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope 116 (2006) 705-710
22. Greven K.M., Williams III D.W., Keyes Jr. J.W., et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 74 (1994) 1355-1359
23. Yao M., Luo P., Hoffman H.T., et al. Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment. Am J Clin Oncol 30 (2007) 264-270
24. Tan A., Adelstein D.J., Rybicki L.A., et al. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Arch Otolaryngol Head Neck Surg 133 (2007) 435-440
25. Clayman G.L., Johnson II C.J., Morrison W., et al. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 127 (2001) 135-139
26. Adelstein D.J., Saxton J.P., Rybicki L.A., et al. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: Mature results from a single institution. J Clin Oncol 24 (2006) 1064-1071
27. Lavertu P., Adelstein D.J., Saxton J.P., et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 19 (1997) 559-566
28. Ellis E.R., Mendenhall W.M., Rao P.V., et al. Incisional or excisional neck-node biopsy before definitive radiotherapy, alone or followed by neck dissection. Head Neck 13 (1991) 177-183
29. Brizel D.M., and Esclamado R. Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: Consensus, controversy, and conundrum. J Clin Oncol 24 (2006) 2612-2617
30. Bernier J., and Bataini J.P. Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy. Analysis of neck disease response in 1646 cases. Radiother Oncol 6 (1986) 87-103
31. Mabanta S.R., Menenhall W.M., Stringer S.P., et al. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck 21 (1999) 591-594
32. Temam S., Pape E., Janot F., et al. Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 62 (2005) 1078-1083
33. Liauw S.L., Amdur R.J., Morris C.G., et al. Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: Salvage in the dissected or undissected neck. Head Neck 29 (2007) 715-719
34. Boyd T.S., Harari P.M., Tannehill S.P., et al. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck 20 (1998) 132-137
35. Doweck I., Robbins K.T., Mendenhall W.M., et al. Neck level-specific nodal metastases in oropharyngeal cancer: Is there a role for selective neck dissection after definitive radiation therapy?. Head Neck 25 (2003) 960-967
36. Simon C., Goepfert H., Rosenthal D.I., et al. Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival. Eur Arch Otorhinolaryngol 263 (2006) 313-318
37. Lango M., Genevieve A., Andrews S.A., et al. Post-radiotherapy neck dissection for head and neck squamous cell carcinoma: Pattern of pathologic residual carcinoma and prognosis (2008) (in press)
38. Yeung A.R., Liauw S.L., Amdur R.J., et al. Lymph node-positive head and neck cancer treated with definitive radiotherapy: Can treatment response determine the extent of neck dissection?. Cancer 112 (2008) 1076-1082
39. Stenson K.M., Huo D., Blair E., et al. Planned post-chemoradiation neck dissection: Significance of radiation dose. Laryngoscope 116 (2006) 33-36